Market Closed -
Other stock markets
|
After market 06:32:19 pm | |||
154.2 USD | +1.02% | 153.8 | -0.29% |
May. 16 | Johnson & Johnson to Buy Proteologix For $850 Million in Cash | MT |
May. 16 | Sector Update: Health Care Stocks Steady Premarket Thursday | MT |
Financials (USD)
Sales 2024 * | 88.37B | Sales 2025 * | 90.78B | Capitalization | 367B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B | Net income 2025 * | 23.09B | EV / Sales 2024 * | 4.08 x |
Net cash position 2024 * | 7B | Net cash position 2025 * | 21.07B | EV / Sales 2025 * | 3.82 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
16.2
x | Employees | 131,900 |
Yield 2024 * |
3.13% | Yield 2025 * |
3.27% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | +1.02% | ||
1 week | +3.54% | ||
Current month | +6.67% | ||
1 month | +4.50% | ||
3 months | -2.34% | ||
6 months | +3.65% | ||
Current year | -1.60% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 88-12-31 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 97-12-31 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 19-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 19-04-24 |
D. Davis
BRD | Director/Board Member | 72 | 14-06-18 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 09-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.01% | 254 M€ | +10.74% | - | |
12.91% | 17 M€ | +7.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 154.3 | +1.05% | 7,590,663 |
24-05-15 | 152.7 | +0.85% | 5,547,955 |
24-05-14 | 151.4 | +0.11% | 8,254,171 |
24-05-13 | 151.2 | +0.87% | 5,628,467 |
24-05-10 | 149.9 | +0.04% | 5,710,566 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.60% | 367B | |
+32.36% | 709B | |
+30.77% | 595B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B | |
+0.45% | 163B |
- Stock Market
- Equities
- JNJ Stock